Glaxo/Innoviva's Trelegy Ellipta Gets FDA Nod for Asthma
Zacks via Yahoo Finance· 6 months agoGlaxoSmithKline plc GSK and partner Innoviva, Inc. INVA announced that the FDA has granted approval...
GSK's 3-in-1 inhalable drug shows promise in asthma study
Reuters via Yahoo News· 2 years agoThe results come at a time when GSK is hit by generic competition for its blockbuster asthma...
Theravance Biopharma Inc. (TBPH) Q1 2019 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 years agoWe are conducting this Phase 2b/3 study in ulcerative colitis patients in parallel with the Phase 2...
Pharma Stock Roundup: AZN & PFE's Coronavirus Vaccine Updates & FDA Approvals
Zacks via Yahoo Finance· 6 months agoThis week the COVID-19 vaccine developers pledged to observe high ethical standards and sound...
GSK's three-drug inhaler wins U.S. nod for use in asthma patients
Reuters via Yahoo News· 6 months agoGSK said the new target population for Trelegy Ellipta amounts to the about 1.7 million adult...
What's in Store for Innoviva (INVA) This Earnings Season?
Zacks via Yahoo Finance· 1 month agoThe trailing four-quarter earnings surprise is 33.09%, on average. In the last reported quarter,...
Glaxo (GSK) Q4 Earnings Lag Estimates, Shingrix Back on Track
Zacks via Yahoo Finance· 4 weeks agoGlaxoSmithKline plc GSK reported fourth-quarter 2020 adjusted earnings of 62 cents per American...
AstraZeneca's Triple-Combo COPD Inhaler Gets CRL From FDA
Zacks via Yahoo Finance· 1 year agoAstraZeneca plc AZN announced that the FDA has given a complete response letter to its new drug...
Will Glaxo (GSK) Q4 Earnings Recover From Coronavirus Woes?
Zacks via Yahoo Finance· 1 month agoGlaxoSmithKline plc GSK will report fourth-quarter 2020 results on Feb 3, before market open. Shares...
Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong
Zacks via Yahoo Finance· 2 years agoGlaxoSmithKline plc GSK reported second-quarter 2019 adjusted earnings of 78 cents per American...
Yahoo Web Search
Trending Now
